Evidence map›Paper›PMID 35906539›Full record

ArticleBMC cardiovascular disorders2022

Surgical treatment of patients with infective endocarditis: changes in temporal use, patient characteristics, and mortality-a nationwide study.

Andreas Dalsgaard Jensen, Lauge Østergaard, Jeppe K Petersen, Peter Graversen, Jawad H Butt, Henning Bundgaard, Claus Moser, Morten H Smerup, Ivy S Modrau, Kasper Iversen and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Infective endocarditis in a university hospital without on-site cardiac surgery: temporal trends over 37 years.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Infective endocarditis: it takes a team.European heart journal · 2025
    Review
  11. Article
  12. Implications of pacemaker implantation after aortic valve surgery for endocarditis: a nationwide study†.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
    Observational
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Infective endocarditis in developing countries: An update.Frontiers in cardiovascular medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Andreas Dalsgaard JensenDepartment of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. andreas@maehle.dk.
Lauge ØstergaardDepartment of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Jeppe K PetersenDepartment of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Peter GraversenDepartment of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Jawad H ButtDepartment of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Henning BundgaardDepartment of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Claus MoserDepartment of Clinical Microbiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Morten H SmerupDepartment of Thoracic Surgery, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
Ivy S ModrauDepartment of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, Denmark.
Kasper IversenDepartment of Emergency Medicine, Copenhagen University Hospital Herlev/Gentofte, Herlev, Denmark.
Niels E BruunDepartment of Cardiology, Zealand University Hospital, Roskilde, Denmark.
Christian Torp-PedersenClinical Institutes, Aalborg University, Aalborg, Denmark.
Gunnar GislasonDepartment of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark.
Andrew WangDepartment of Cardiology, Duke Medical Center, Duke University, Durham, NC, USA.
Sigurdur RagnarssonDepartment of Cardiothoracic Surgery, Skaane University Hospital, Lund, Sweden.
Jonas A PovlsenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Lars KøberDepartment of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Emil L FosbølDepartment of Cardiology, The Heart Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Copenhagen University Hospital · DKUniversity of Copenhagen · DKAarhus University Hospital · DKRigshospitalet · DKDuke Medical Center · USFrederiksberg Hospital · DKSkåne University Hospital · SEZealand University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundValve surgery guidelines for infective endocarditis (IE) are unchanged over decades and nationwide data about the use of valve surgery do not exist.

methodsWe included patients with first-time IE (1999-2018) using Danish nationwide registries. Proportions of valve surgery were reported for calendar periods (1999-2003, 2004-2008, 2009-2013, 2014-2018). Comparing calendar periods in multivariable analyses, we computed likelihoods of valve surgery with logistic regression and rates of 30 day postoperative mortality with Cox regression.

resultsWe included 8804 patients with first-time IE; 1981 (22.5%) underwent surgery during admission, decreasing by calendar periods (N = 360 [24.4%], N = 483 [24.0%], N = 553 [23.5%], N = 585 [19.7%], P = < 0.001 for trend). For patients undergoing valve surgery, median age increased from 59.7 to 66.9 years (P ≤ 0.001) and the proportion of males increased from 67.8% to 72.6% (P = 0.008) from 1999-2003 to 2014-2018. Compared with 1999-2003, associated likelihoods of valve surgery were: Odds ratio (OR) = 1.14 (95% CI: 0.96-1.35), OR = 1.20 (95% CI: 1.02-1.42), and OR = 1.10 (95% CI: 0.93-1.29) in 2004-2008, 2009-2013, and 2014-2018, respectively. 30 day postoperative mortalities were: 12.7%, 12.8%, 6.9%, and 9.7% by calendar periods. Compared with 1999-2003, associated mortality rates were: Hazard ratio (HR) = 0.96 (95% CI: 0.65-1.41), HR = 0.43 (95% CI: 0.28-0.67), and HR = 0.55 (95% CI 0.37-0.83) in 2004-2008, 2009-2013, and 2014-2018, respectively.

conclusionsOn a nationwide scale, 22.5% of patients with IE underwent valve surgery. Patient characteristics changed considerably and use of valve surgery decreased over time. The adjusted likelihood of valve surgery was similar between calendar periods with a trend towards an increase while rates of 30 day postoperative mortality decreased.

Indexed as

EndocarditisEndocarditis, BacterialHeart Valve Prosthesis ImplantationAgedHumansMaleMiddle AgedOdds RatioProportional Hazards ModelsRegistriesCardiac valve surgeryEpidemiologyInfective endocarditisTemporal trend

Identifiers

PMID35906539
PMCPMC9336053
OpenAlexW4288515310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.